Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier ...
Mangaciclanol’s Phase I trial showed it was well tolerated, with no serious adverse events or clinically significant findings ...
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best NASDAQ stocks with the highest upside potential.
Zacks Small Cap Research on MSN
RADX: RAD 101 phase IIb interim analysis
By John Vandermosten, CFA NASDAQ: RADX RAD 101 Phase IIb Second Interim Data Analysis Approximately three months after the first interim readout from the RAD 101 Phase IIb trial, Radiopharm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results